ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-30E16988
Home | Market Reports | Health| Medical Devices & Equipment
Global Activated Clotting Time ACT Cartridge Market Research Report 2024
BUY CHAPTERS

Global Activated Clotting Time (ACT) Cartridge Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30E16988
Report
October 2025
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Calbiotech
Anogen
Sienco
BioDee
Kanglang Biotechnology
X-Y Biotechnology

Activated Clotting Time (ACT) Cartridge Market

The global Activated Clotting Time (ACT) Cartridge market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Activated Clotting Time (ACT) Cartridge leading manufacturers including Medtronic, Abbott, Calbiotech, Anogen, Sienco, BioDee, Kanglang Biotechnology, X-Y Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Activated Clotting Time (ACT) Cartridge market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Activated Clotting Time (ACT) Cartridge Market Report

Report Metric Details
Report Name Activated Clotting Time (ACT) Cartridge Market
Segment by Type
  • Enzyme-linked Immunosorbent Assay
  • Coagulation Method
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Abbott, Calbiotech, Anogen, Sienco, BioDee, Kanglang Biotechnology, X-Y Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Activated Clotting Time (ACT) Cartridge study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Activated Clotting Time (ACT) Cartridge Market report?

Ans: The main players in the Activated Clotting Time (ACT) Cartridge Market are Medtronic, Abbott, Calbiotech, Anogen, Sienco, BioDee, Kanglang Biotechnology, X-Y Biotechnology

What are the Application segmentation covered in the Activated Clotting Time (ACT) Cartridge Market report?

Ans: The Applications covered in the Activated Clotting Time (ACT) Cartridge Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Activated Clotting Time (ACT) Cartridge Market report?

Ans: The Types covered in the Activated Clotting Time (ACT) Cartridge Market report are Enzyme-linked Immunosorbent Assay, Coagulation Method, Others

1 Study Coverage
1.1 Introduction to Activated Clotting Time (ACT) Cartridge: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Activated Clotting Time (ACT) Cartridge Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Enzyme-linked Immunosorbent Assay
1.2.3 Coagulation Method
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Activated Clotting Time (ACT) Cartridge Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Activated Clotting Time (ACT) Cartridge Revenue Estimates and Forecasts 2020-2031
2.2 Global Activated Clotting Time (ACT) Cartridge Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Activated Clotting Time (ACT) Cartridge Sales Estimates and Forecasts 2020-2031
2.4 Global Activated Clotting Time (ACT) Cartridge Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Activated Clotting Time (ACT) Cartridge Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Activated Clotting Time (ACT) Cartridge Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Enzyme-linked Immunosorbent Assay Market Size by Manufacturers
3.5.2 Coagulation Method Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Activated Clotting Time (ACT) Cartridge Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Activated Clotting Time (ACT) Cartridge Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Activated Clotting Time (ACT) Cartridge Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Activated Clotting Time (ACT) Cartridge Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Activated Clotting Time (ACT) Cartridge Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Activated Clotting Time (ACT) Cartridge Sales and Revenue by Type (2020-2031)
6.4 North America Activated Clotting Time (ACT) Cartridge Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Activated Clotting Time (ACT) Cartridge Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Activated Clotting Time (ACT) Cartridge Sales and Revenue by Type (2020-2031)
7.4 Europe Activated Clotting Time (ACT) Cartridge Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Activated Clotting Time (ACT) Cartridge Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Activated Clotting Time (ACT) Cartridge Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Activated Clotting Time (ACT) Cartridge Sales and Revenue by Type (2020-2031)
9.4 Central and South America Activated Clotting Time (ACT) Cartridge Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Activated Clotting Time (ACT) Cartridge Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Activated Clotting Time (ACT) Cartridge Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Activated Clotting Time (ACT) Cartridge Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Activated Clotting Time (ACT) Cartridge Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.1.4 Medtronic Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Activated Clotting Time (ACT) Cartridge Sales by Product in 2024
11.1.6 Medtronic Activated Clotting Time (ACT) Cartridge Sales by Application in 2024
11.1.7 Medtronic Activated Clotting Time (ACT) Cartridge Sales by Geographic Area in 2024
11.1.8 Medtronic Activated Clotting Time (ACT) Cartridge SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.2.4 Abbott Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Activated Clotting Time (ACT) Cartridge Sales by Product in 2024
11.2.6 Abbott Activated Clotting Time (ACT) Cartridge Sales by Application in 2024
11.2.7 Abbott Activated Clotting Time (ACT) Cartridge Sales by Geographic Area in 2024
11.2.8 Abbott Activated Clotting Time (ACT) Cartridge SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Calbiotech
11.3.1 Calbiotech Corporation Information
11.3.2 Calbiotech Business Overview
11.3.3 Calbiotech Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.3.4 Calbiotech Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Calbiotech Activated Clotting Time (ACT) Cartridge Sales by Product in 2024
11.3.6 Calbiotech Activated Clotting Time (ACT) Cartridge Sales by Application in 2024
11.3.7 Calbiotech Activated Clotting Time (ACT) Cartridge Sales by Geographic Area in 2024
11.3.8 Calbiotech Activated Clotting Time (ACT) Cartridge SWOT Analysis
11.3.9 Calbiotech Recent Developments
11.4 Anogen
11.4.1 Anogen Corporation Information
11.4.2 Anogen Business Overview
11.4.3 Anogen Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.4.4 Anogen Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Anogen Activated Clotting Time (ACT) Cartridge Sales by Product in 2024
11.4.6 Anogen Activated Clotting Time (ACT) Cartridge Sales by Application in 2024
11.4.7 Anogen Activated Clotting Time (ACT) Cartridge Sales by Geographic Area in 2024
11.4.8 Anogen Activated Clotting Time (ACT) Cartridge SWOT Analysis
11.4.9 Anogen Recent Developments
11.5 Sienco
11.5.1 Sienco Corporation Information
11.5.2 Sienco Business Overview
11.5.3 Sienco Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.5.4 Sienco Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sienco Activated Clotting Time (ACT) Cartridge Sales by Product in 2024
11.5.6 Sienco Activated Clotting Time (ACT) Cartridge Sales by Application in 2024
11.5.7 Sienco Activated Clotting Time (ACT) Cartridge Sales by Geographic Area in 2024
11.5.8 Sienco Activated Clotting Time (ACT) Cartridge SWOT Analysis
11.5.9 Sienco Recent Developments
11.6 BioDee
11.6.1 BioDee Corporation Information
11.6.2 BioDee Business Overview
11.6.3 BioDee Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.6.4 BioDee Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 BioDee Recent Developments
11.7 Kanglang Biotechnology
11.7.1 Kanglang Biotechnology Corporation Information
11.7.2 Kanglang Biotechnology Business Overview
11.7.3 Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.7.4 Kanglang Biotechnology Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Kanglang Biotechnology Recent Developments
11.8 X-Y Biotechnology
11.8.1 X-Y Biotechnology Corporation Information
11.8.2 X-Y Biotechnology Business Overview
11.8.3 X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Product Models, Descriptions and Specifications
11.8.4 X-Y Biotechnology Activated Clotting Time (ACT) Cartridge Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 X-Y Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Activated Clotting Time (ACT) Cartridge Industry Chain
12.2 Activated Clotting Time (ACT) Cartridge Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Activated Clotting Time (ACT) Cartridge Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Activated Clotting Time (ACT) Cartridge Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Activated Clotting Time (ACT) Cartridge Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Activated Clotting Time (ACT) Cartridge Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Abbott
Calbiotech
Anogen
Sienco
BioDee
Kanglang Biotechnology
X-Y Biotechnology
List of Tables
 Table 1. Global Activated Clotting Time (ACT) Cartridge Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Activated Clotting Time (ACT) Cartridge Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Activated Clotting Time (ACT) Cartridge Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Activated Clotting Time (ACT) Cartridge Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Activated Clotting Time (ACT) Cartridge Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Activated Clotting Time (ACT) Cartridge Sales by Region (2020-2025) & (K Units)
 Table 8. Global Activated Clotting Time (ACT) Cartridge Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Activated Clotting Time (ACT) Cartridge Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Activated Clotting Time (ACT) Cartridge Sales Share by Manufacturers (2020-2025)
 Table 12. Global Activated Clotting Time (ACT) Cartridge Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Activated Clotting Time (ACT) Cartridge by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Activated Clotting Time (ACT) Cartridge as of 2024)
 Table 16. Global Activated Clotting Time (ACT) Cartridge Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Activated Clotting Time (ACT) Cartridge Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Activated Clotting Time (ACT) Cartridge Manufacturing Base and Headquarters
 Table 19. Global Activated Clotting Time (ACT) Cartridge Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Activated Clotting Time (ACT) Cartridge Sales by Type (2020-2025) & (K Units)
 Table 23. Global Activated Clotting Time (ACT) Cartridge Sales by Type (2026-2031) & (K Units)
 Table 24. Global Activated Clotting Time (ACT) Cartridge Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Activated Clotting Time (ACT) Cartridge Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Activated Clotting Time (ACT) Cartridge ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Activated Clotting Time (ACT) Cartridge Sales by Application (2020-2025) & (K Units)
 Table 29. Global Activated Clotting Time (ACT) Cartridge Sales by Application (2026-2031) & (K Units)
 Table 30. Activated Clotting Time (ACT) Cartridge High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Activated Clotting Time (ACT) Cartridge Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Activated Clotting Time (ACT) Cartridge Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Activated Clotting Time (ACT) Cartridge ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Activated Clotting Time (ACT) Cartridge Growth Accelerators and Market Barriers
 Table 37. North America Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Activated Clotting Time (ACT) Cartridge Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Activated Clotting Time (ACT) Cartridge Growth Accelerators and Market Barriers
 Table 40. Europe Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Activated Clotting Time (ACT) Cartridge Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Activated Clotting Time (ACT) Cartridge Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Activated Clotting Time (ACT) Cartridge Investment Opportunities and Key Challenges
 Table 47. Central and South America Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Activated Clotting Time (ACT) Cartridge Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Activated Clotting Time (ACT) Cartridge Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Medtronic Corporation Information
 Table 51. Medtronic Description and Major Businesses
 Table 52. Medtronic Product Models, Descriptions and Specifications
 Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Medtronic Sales Value Proportion by Product in 2024
 Table 55. Medtronic Sales Value Proportion by Application in 2024
 Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 57. Medtronic Activated Clotting Time (ACT) Cartridge SWOT Analysis
 Table 58. Medtronic Recent Developments
 Table 59. Abbott Corporation Information
 Table 60. Abbott Description and Major Businesses
 Table 61. Abbott Product Models, Descriptions and Specifications
 Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abbott Sales Value Proportion by Product in 2024
 Table 64. Abbott Sales Value Proportion by Application in 2024
 Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 66. Abbott Activated Clotting Time (ACT) Cartridge SWOT Analysis
 Table 67. Abbott Recent Developments
 Table 68. Calbiotech Corporation Information
 Table 69. Calbiotech Description and Major Businesses
 Table 70. Calbiotech Product Models, Descriptions and Specifications
 Table 71. Calbiotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Calbiotech Sales Value Proportion by Product in 2024
 Table 73. Calbiotech Sales Value Proportion by Application in 2024
 Table 74. Calbiotech Sales Value Proportion by Geographic Area in 2024
 Table 75. Calbiotech Activated Clotting Time (ACT) Cartridge SWOT Analysis
 Table 76. Calbiotech Recent Developments
 Table 77. Anogen Corporation Information
 Table 78. Anogen Description and Major Businesses
 Table 79. Anogen Product Models, Descriptions and Specifications
 Table 80. Anogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Anogen Sales Value Proportion by Product in 2024
 Table 82. Anogen Sales Value Proportion by Application in 2024
 Table 83. Anogen Sales Value Proportion by Geographic Area in 2024
 Table 84. Anogen Activated Clotting Time (ACT) Cartridge SWOT Analysis
 Table 85. Anogen Recent Developments
 Table 86. Sienco Corporation Information
 Table 87. Sienco Description and Major Businesses
 Table 88. Sienco Product Models, Descriptions and Specifications
 Table 89. Sienco Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Sienco Sales Value Proportion by Product in 2024
 Table 91. Sienco Sales Value Proportion by Application in 2024
 Table 92. Sienco Sales Value Proportion by Geographic Area in 2024
 Table 93. Sienco Activated Clotting Time (ACT) Cartridge SWOT Analysis
 Table 94. Sienco Recent Developments
 Table 95. BioDee Corporation Information
 Table 96. BioDee Description and Major Businesses
 Table 97. BioDee Product Models, Descriptions and Specifications
 Table 98. BioDee Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. BioDee Recent Developments
 Table 100. Kanglang Biotechnology Corporation Information
 Table 101. Kanglang Biotechnology Description and Major Businesses
 Table 102. Kanglang Biotechnology Product Models, Descriptions and Specifications
 Table 103. Kanglang Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Kanglang Biotechnology Recent Developments
 Table 105. X-Y Biotechnology Corporation Information
 Table 106. X-Y Biotechnology Description and Major Businesses
 Table 107. X-Y Biotechnology Product Models, Descriptions and Specifications
 Table 108. X-Y Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. X-Y Biotechnology Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Activated Clotting Time (ACT) Cartridge Product Picture
 Figure 2. Global Activated Clotting Time (ACT) Cartridge Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Enzyme-linked Immunosorbent Assay Product Picture
 Figure 4. Coagulation Method Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Activated Clotting Time (ACT) Cartridge Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Activated Clotting Time (ACT) Cartridge Report Years Considered
 Figure 11. Global Activated Clotting Time (ACT) Cartridge Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Activated Clotting Time (ACT) Cartridge Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Region (2020-2031)
 Figure 15. Global Activated Clotting Time (ACT) Cartridge Sales (2020-2031) & (K Units)
 Figure 16. Global Activated Clotting Time (ACT) Cartridge Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Volume Market Share in 2024
 Figure 19. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Enzyme-linked Immunosorbent Assay Revenue Market Share by Manufacturer in 2024
 Figure 22. Coagulation Method Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Type (2020-2031)
 Figure 25. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Type (2020-2031)
 Figure 26. Global Activated Clotting Time (ACT) Cartridge Sales Market Share by Application (2020-2031)
 Figure 27. Global Activated Clotting Time (ACT) Cartridge Revenue Market Share by Application (2020-2031)
 Figure 28. North America Activated Clotting Time (ACT) Cartridge Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Activated Clotting Time (ACT) Cartridge Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) in 2024
 Figure 31. North America Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Activated Clotting Time (ACT) Cartridge Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Activated Clotting Time (ACT) Cartridge Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 46. France Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Activated Clotting Time (ACT) Cartridge Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 61. India Activated Clotting Time (ACT) Cartridge Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Activated Clotting Time (ACT) Cartridge Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Activated Clotting Time (ACT) Cartridge Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Activated Clotting Time (ACT) Cartridge Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Activated Clotting Time (ACT) Cartridge Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Activated Clotting Time (ACT) Cartridge Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Activated Clotting Time (ACT) Cartridge Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Activated Clotting Time (ACT) Cartridge Revenue (2020-2025) & (US$ Million)
 Figure 82. Activated Clotting Time (ACT) Cartridge Industry Chain Mapping
 Figure 83. Regional Activated Clotting Time (ACT) Cartridge Manufacturing Base Distribution (%)
 Figure 84. Global Activated Clotting Time (ACT) Cartridge Production Market Share by Region (2020-2031)
 Figure 85. Activated Clotting Time (ACT) Cartridge Production Process
 Figure 86. Regional Activated Clotting Time (ACT) Cartridge Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Activated Clotting Time Testing Market Insights Forecast to 2030
Global Activated Carbon Filter Cartridge Market Research Report 2024
Global Membrane Cartridges Market Research Report 2025
Global Solid Phase Extraction Cartridges Market Research Report 2024
Global Blood Clots Instrument Market Research Report 2024
Prothrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Test Cartridges Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dual Chamber Injection Cartridge Market Research Report 2025
Global Live Resin Cartridge Market Research Report 2025
Global Resin Bonded Filter Cartridges Market Research Report 2025
Global Commercial Cartridge Filters Market Research Report 2024
Global Activated Partial Thromboplastin Market Research Report 2024
Global Cartridges for RT PCR Automatic Systems Market Research Report 2024
Thrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Resin Hemoperfusion Cartridge Market Research Report 2025
Global Microfluidics Cartridge Market Research Report 2024
Global Replacement Filter Cartridges Market Research Report 2024
Global Medicine Cartridge Market Research Report 2024
Global Cartridges Market Research Report 2025
Activated Partial Thromboplastin Time Testing APTT Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions